Canary Speech’s Five-Year Sale: Why Healthcare’s “Slow” Buyers Are Actually Your Competitive Moat

Henry O’Connell spent five years on one healthcare deal before closing. Most founders quit. He reveals why long sales cycles aren’t bugs—they’re the moat that keeps competitors out of healthcare.

Written By: Brett

0

Canary Speech’s Five-Year Sale: Why Healthcare’s “Slow” Buyers Are Actually Your Competitive Moat

Canary Speech’s Five-Year Sale: Why Healthcare’s “Slow” Buyers Are Actually Your Competitive Moat

Your sales cycle is too long. That’s what every SaaS playbook tells you. Compress the timeline. Add urgency. Close faster. Long sales cycles mean weak positioning or unclear value.

In a recent episode of Category Visionaries, Henry O’Connell, CEO and Founder of Canary Speech, shared why he spent five years nurturing one healthcare relationship before closing—and why that “failure” became his entire go-to-market strategy.

The Five-Year “Problem”

Five years ago, Henry presented to a healthcare company’s board. The pitch went well. The board understood the value and believed in the technology.

Then nothing happened.

“We’re working with one of the organizations, healthcare companies, that five years ago was the first introduction. And I spoke to their board of directors nearly five years ago, presented what we were doing. And the truth is, even then, there was a belief on their part that what we were doing was both important and quite real.”

For most founders, this is where the story ends. You move on. Find faster buyers. But Henry stayed engaged for five years before that institution became a customer.

What Most Founders Miss

Conventional wisdom treats long sales cycles as friction to eliminate. Henry saw something else: “I stayed connected with this healthcare institution because frankly, I liked the people, I trusted them. They were just solid as a rock, credible people, and they gave us input.”

This wasn’t passive waiting. The institution provided something more valuable than a quick sale: insight into real-world implementation. “They also gave us insight into how it might impact in the organization. How would you bring it in so that it was positive and it augmented this interaction between patient and doctor. Those are the kind of insights that you, just as a small company, even as a large company, you’re not going to get them unless you’re integrated into and working with customers like that.”

The five-year relationship wasn’t a bug—it was co-development disguised as a sales cycle.

Why Healthcare Actually Moves This Way

The frustration founders feel isn’t bureaucracy—it’s misunderstanding the dynamics. “Healthcare markets don’t change. They don’t change quickly. Their processes, their procedures, the tools they use are being used in situations and circumstances that are critical, life saving in many cases.”

This is rational behavior, not resistance. When tools are deployed in life-saving situations, rapid adoption of unproven technology isn’t innovation—it’s malpractice. The five-year timeline reflects healthcare doing what it should: thoroughly validating before deploying at scale.

You’re not fighting bureaucracy. You’re navigating different risk tolerances. The sales cycle isn’t too long—your expectations are wrong.

The Compound Effect Nobody Talks About

That five-year relationship didn’t just result in one customer. It unlocked an ecosystem. The institution invested in Canary Speech three years ago. That investment created credibility leading to other partnerships. The relationship created pathways to Microsoft, which had acquired Nuance. Microsoft invested $1.5 million in non-dilutive grants and integrated Canary Speech into Azure.

This morning, Henry was on a call with Abu Dhabi prospects—a lead from Microsoft. One five-year relationship created a network effect that continues expanding.

The math is counterintuitive: one five-year relationship that unlocks a network beats fifty transactional deals leading nowhere. The compound effect doesn’t show up in quarterly metrics, but it determines who survives.

The Competitive Moat Hidden in Plain Sight

Here’s what Henry understood: long sales cycles aren’t obstacles—they’re barriers to entry. If you need five years of relationship building before closing deals, most startups can’t compete. They’ll run out of capital, patience, or founder energy.

“It’s a combination of persistence and patience,” Henry says. Most venture-backed startups have neither. They have quarterly board meetings demanding growth, investors expecting returns, and burn rates that don’t accommodate five-year cycles.

By staying engaged, Canary Speech built what competitors can’t replicate: trust earned through years of collaboration. New entrants can build similar technology, raise more money, and hire better people. But they can’t buy five years of earned trust.

What This Means for Capital Strategy

None of this works with traditional venture capital. If investors expect three-year returns and customers need five-year validation, you’ve created structural misalignment that will destroy the company.

Henry’s advice: “From an investment standpoint, be patient. Choose people who have the same belief and philosophy that you do.” For Canary Speech, this meant non-dilutive grants from Microsoft, strategic investment from customers, and patient capital that could survive long cycles.

The capital structure must match market reality. If healthcare requires five-year sales cycles, your funding needs to accommodate that timeline.

The Framework for Long-Cycle Sales

The decision to invest five years followed a logic other founders can apply:

Evaluate relationship quality over transaction potential. Henry stayed engaged because he “liked the people” and “trusted them.” In long-cycle markets, relationship quality determines survival.

Extract value throughout the cycle. The insights about implementation and workflow integration were valuable regardless of whether the sale closed.

One deep relationship creates network effects. The institution that invested unlocked Microsoft. Microsoft unlocked international opportunities.

When to Walk Away

The critical question isn’t whether to invest in long-cycle sales—it’s knowing which relationships warrant five years. Not every prospect deserves this investment.

Henry’s filter was simple: the people were credible, they provided valuable input, and they were genuinely engaged. If any element was missing, the five-year investment wouldn’t make sense.

The relationship worked because it was mutual. The institution was also investing—time, expertise, strategic thinking. It wasn’t vendor-buyer. It was partnership that happened to include a transaction.

What This Means for You

If you’re building in healthcare or regulated markets with long validation cycles, stop treating the timeline as a problem. The founders who win aren’t the ones who compress six-month cycles into three months. They’re the ones who understand that five-year cycles keep out competitors who can’t sustain patience.

“You’ve got to put the stake in the ground, and that stake may be three years out, it may be eight years out, it may be ten years out.”

Eight years after starting Canary Speech, that five-year customer relationship still pays dividends through network effects and ecosystem partnerships. The “slow” buyer became the strategic asset that built the company.

The question isn’t how to make healthcare buy faster. It’s whether you can build a company that survives long enough for healthcare to buy at all.